Oppenheimer Warns Raptor Pharma Could Fall By ~50%, Suggests 'Sell While You Can'

By: via Benzinga
In a report published Monday, Oppenheimer analyst Christopher Marai downgraded the rating on Raptor Pharmaceutical Corp. (NASDAQ: RPTP) ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.